CIK 0001638097
- Non-accelerated filer
- Smaller reporting company
Entera Bio Ltd.
Sign in to watch- Ticker
- ENTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 25327151
- Business address
- KIRYAT HADASSAH, MINRAV BUILDING, FIFTH FLOOR, JERUSALEM, Israel, 9112002
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Director acquired 7,278 shares (grant or award)
- 4 Grant or award Director acquired 8,452 shares (grant or award)
- 4 Grant or award Director acquired 8,639 shares (grant or award)
- 4 Grant or award Director acquired 11,269 shares (grant or award)
- 4 Grant or award Director acquired 7,466 shares (grant or award)
- 4 Grant or award Director acquired 20,446 shares (grant or award)
- 4 Grant or award Director acquired 15,335 shares (grant or award)
- 4 Grant or award Director acquired 18,061 shares (grant or award)
- 4 Grant or award Director acquired 23,172 shares (grant or award)
- 4 Grant or award Director acquired 27,261 shares (grant or award)
- 4/A Grant or award Chief Financial Officer acquired 30,151 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 124,121 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 30,151 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 30,151 shares (grant or award)
- 4 Open-market buy Director bought 9,500 shares at $0.99 ($9,405)
- 4 Open-market buy Director bought 7,615 shares at $0.77 ($5,864)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 7 · 126 filings